TNFRSF13C and B-cell chronic lymphocytic leukemia: Intriguingly, administration of decoy receptor BCMA (which binds to both BAFF and APRIL), but not BAFF-blocker BAFF-R:Fc, impairs the survival of CLL cells, suggesting a dominant role for APRIL in the interaction between CLL cells and NLCs.